Armand P, Zinzani PL, Lee HJ, Johnson NA, et al. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy in relapsed/refractory classical Hodgkin lymphoma. Blood 2023 Jun 15:blood.2022019386. doi: 10.1182/blood.2022019386.
PMID: 37319435